Eli Lilly and Co (LLY) Earns "Buy" Rating from Jefferies Group


's stock had its "buy" rating restated by equities researchers at Jefferies Group in a research report issued on Monday, ARN reports. They currently have a $125.00 price objective on the stock.



from Biotech News